1. Home
  2. MYRG vs RLAY Comparison

MYRG vs RLAY Comparison

Compare MYRG & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MYR Group Inc.

MYRG

MYR Group Inc.

HOLD

Current Price

$390.93

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$19.73

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYRG
RLAY
Founded
1891
2015
Country
United States
United States
Employees
9000
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
4.1B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
MYRG
RLAY
Price
$390.93
$19.73
Analyst Decision
Buy
Strong Buy
Analyst Count
8
10
Target Price
$262.43
$19.50
AVG Volume (30 Days)
303.0K
4.2M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
311.48
31.78
EPS
2.99
N/A
Revenue
$1,531,169,000.00
$15,355,000.00
Revenue This Year
$11.87
N/A
Revenue Next Year
$8.48
$324.03
P/E Ratio
$132.76
N/A
Revenue Growth
N/A
53.44
52 Week Low
$171.51
$3.03
52 Week High
$503.57
$20.79

Technical Indicators

Market Signals
Indicator
MYRG
RLAY
Relative Strength Index (RSI) 36.42 62.76
Support Level $251.81 $12.10
Resistance Level $485.92 $20.79
Average True Range (ATR) 22.13 1.31
MACD -7.30 -0.09
Stochastic Oscillator 12.91 73.40

Price Performance

Historical Comparison
MYRG
RLAY

About MYRG MYR Group Inc.

MYR Group Inc is a U.S. based holding company of specialty electrical construction service providers. Through its subsidiaries, it serves electric utility, commercial, and industrial construction markets in the United States and Canada, offering services such as design, engineering, procurement, construction, upgrades, maintenance, and repair, with a focus on construction, maintenance, and repair work. The company operates through two segments: Transmission and Distribution (T&D) and Commercial and Industrial (C&I). The majority of revenue is derived from the T&D segment, which provides a range of services on electric transmission and distribution networks and substation facilities, which include design, engineering, procurement, construction, upgrade and maintenance and repair services.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: